Surgical Gastroenterology Unit, Department of Surgery, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, South Africa.
Division of Interdisciplinary Palliative Care and Medicine, Department of Family Community and Emergency Care, Faculty of Health Sciences, University of Cape Town, South Africa.
S Afr J Surg. 2024 May;62(2):68.
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor survival rates. Timeously introduced palliative care (PC) improves the quality of life (QoL) for patients with terminal diseases. In 2020, an in-patient PC-quality improvement (QI) programme was implemented for PDAC patients. This study compared PC outcomes before and after the introduction of the PC-QI programme.
A focus group identified five critical intervention areas that could improve care. These were in-patient PC referral, pain and symptom control, shared decision-making, interdisciplinary collaborative care, and continuity of care. A hospital record audit of PDAC patients was conducted in pre- and post-implementation cohorts, and the results were compared.
A total of 68 (2017 pre-PC-QI) and 39 (2022 post-PC-QI) patient records were audited. Demography, symptom duration, referral delay, and clinical findings were similar in both cohorts. In-patient PC referrals improved significantly from 54.4% in 2017 to 82.1% in 2022 ( = 0.0059). Significant improvements were also recorded in shared decisionmaking, collaboration, and continuity of care, while the reassessment of pain and symptoms after treatment improved. Fewer invasive procedures were done in the 2022 cohort ( = 0.0056). The delay from admission to an invasive diagnostic procedure decreased from a mean of 8.7 to 1.5 days ( = 0.0001). The duration of hospital admission, overall survival (OS), and readmissions during the final 30 days of life were similar.
The QI programme resulted in improved use of the in-hospital PC service and made better use of scarce resources. Increasing patient and family participation and feedback will further inform the development of the quality of PC services.
胰腺导管腺癌(PDAC)是一种侵袭性恶性肿瘤,生存率低。及时引入姑息治疗(PC)可提高终末期疾病患者的生活质量(QoL)。2020 年,为 PDAC 患者实施了一项住院 PC 质量改进(QI)计划。本研究比较了该计划实施前后 PC 的结果。
一个焦点小组确定了五个可以改善护理的关键干预领域。这些领域包括住院 PC 转诊、疼痛和症状控制、共同决策、跨学科协作护理和护理连续性。对 PDAC 患者进行了实施前后的住院病历审核,并对结果进行了比较。
共审核了 68 例(2017 年 PC-QI 前)和 39 例(2022 年 PC-QI 后)患者的记录。两组患者的人口统计学、症状持续时间、转诊延迟和临床发现相似。住院 PC 转诊率从 2017 年的 54.4%显著提高到 2022 年的 82.1%( = 0.0059)。在共同决策、协作和护理连续性方面也有显著改善,而治疗后疼痛和症状的重新评估也有所改善。2022 年组的侵入性操作较少( = 0.0056)。从入院到侵入性诊断程序的延迟从平均 8.7 天减少到 1.5 天( = 0.0001)。住院时间、总生存期(OS)和生命最后 30 天的再入院率相似。
QI 计划改善了住院 PC 服务的使用,并更好地利用了稀缺资源。增加患者和家属的参与和反馈将进一步为 PC 服务质量的发展提供信息。